Cara Therapeutics's market cap is currently $23.40M. The company's EPS TTM is $-20.989; its P/E ratio is ―; Cara Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 20.97M	$ 41.87M	$ 23.03M	$ 135.08M	$ 19.89M
Gross Profit	$ 14.79M	$ 34.60M	$ 21.47M	$ 28.01M	$ -93.28M
Operating Income	$ -121.50M	$ -87.53M	$ -89.08M	$ 5.38M	$ -111.68M
EBITDA	$ -117.65M	$ -83.80M	$ -88.19M	$ 5.59M	$ -111.48M
Net Income	$ -118.51M	$ -83.41M	$ -88.19M	$ 8.41M	$ -106.37M
Balance Sheet
Cash & Short-Term Investments	$ 100.76M	$ 145.40M	$ 167.03M	$ 180.93M	$ 155.01M
Total Assets	$ 125.84M	$ 182.24M	$ 247.06M	$ 271.16M	$ 232.96M
Total Debt	$ 43.17M	$ 1.92M	$ 3.67M	$ 5.28M	$ 4.32M
Net Debt	$ -8.61M	$ -61.82M	$ -9.78M	$ -26.41M	$ -13.99M
Total Liabilities	$ 68.76M	$ 23.46M	$ 19.53M	$ 22.16M	$ 46.25M
Stockholders' Equity	$ 57.09M	$ 158.78M	$ 227.52M	$ 249.00M	$ 186.71M
Cash Flow
Free Cash Flow	$ -94.45M	$ -78.77M	$ -60.13M	$ -5.84M	$ -109.24M
Operating Cash Flow	$ -92.08M	$ -78.73M	$ -60.09M	$ -5.49M	$ -109.22M
Investing Cash Flow	$ 43.46M	$ 128.71M	$ -4.75M	$ -20.27M	$ -30.52M
Financing Cash Flow	$ 38.15M	$ 311.00K	$ 46.61M	$ 39.14M	$ 142.60M

Currency in USD

Cara Therapeutics Earnings and Revenue History

Income Statement >

Cara Therapeutics Debt to Assets

Balance Sheet >

Cara Therapeutics Cash Flow

Cash Flow >

Cara Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing